HeraMED CEO David Groberman has resigned
SYDNEY, AUSTRALIA: HeraMED Limited (ASX:HMD) announced that Mr David Groberman has resigned as Chief Executive Officer and Managing Director with immediate effect. David will continue in a non-Executive role, as Product Strategist, delivering advice and strategic input on the evolution…